Aniara Diagnostica is pleased to announce the availability of Recombinant Hirudin, a thrombin inhibitor.
WEST CHESTER, OHIO (PRWEB) NOVEMBER 12, 2019
Aniara Diagnostica, a multi-national distributor of diagnostic and research agents, as well as screening tools, has strengthened its commitment to meeting today’s highest standards for product quality and cost-efficient delivery.
For Research Use Only. Not for Use in Diagnostic Procedures.
Recombinant Hirudin is a Thrombin inhibitor, which can be used in any in vitro laboratory research application where an efficient inhibition of Thrombin is required.
ARE120A Recombinant Hirudin (1 x 16,000 ATU) click here for more information
ARE120B Recombinant Hirudin (1 x 160,000 ATU) click here for more information
The entire Aniara product line is available for purchase at http://www.aniara.com. The Company distributes products in North America, Central America, South America, Sweden, Norway, Denmark, Finland, Lithuania, Latvia, Estonia and Iceland.
The entire Aniara line is available for purchase at http://www.aniara.com.
